What Do Medical Journals Say About Cannabis and Panic Disorders?

PostedMarch 3, 2026

UpdatedMarch 3, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Examining medical literature on cannabis for panic provides valuable insight into how cannabinoids may affect anxiety and panic disorder symptoms. Reviewing systematic reviews and peer-reviewed studies helps clarify potential benefits, risks, and treatment strategies. Understanding medical literature on cannabis for panic allows clinicians and patients to make informed decisions based on current clinical reviews.

Insights from Medical Research

Professional interpretation of medical literature on cannabis for panic ensures findings are applied safely and appropriately in patient care.

Systematic Reviews

Systematic reviews summarise existing studies, highlighting overall trends, effectiveness, and safety considerations for cannabis use in panic disorders.

Peer-Reviewed Studies

Individual peer-reviewed studies provide detailed data on dosing, symptom relief, and patient outcomes, contributing to the broader evidence base.

Clinical Reviews

Clinical reviews offer expert evaluations and recommendations based on the collective findings of multiple studies, informing practical approaches for patients and healthcare providers.

In conclusion, medical literature on cannabis for panic demonstrates both potential benefits and limitations. Reviewing systematic reviews, peer-reviewed studies, and clinical reviews helps ensure safe, evidence-based use of cannabis for panic disorder management.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.